Evaluation of antimutagenic activity and mechanisms of action of β-glucan from barley, in CHO-k1 and HTC cell lines using the micronucleus test

Toxicology in Vitro

Volumn 20, Issue 7, 2006, Pages 1225-1233

  Oliveira, Rodrigo Juliano ^a   Ribeiro, Lúcia Regina ^b   da Silva, Ariane Fernanda ^a   Matuo, Renata ^a   Mantovani, Mário Sérgio ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

glucan; Antimutagenesis; CHO k1 cells; HTC cells; Mechanism of action

Indexed keywords

2 AMINOANTHRACENE; BETA GLUCAN; MESYLIC ACID METHYL ESTER; MUTAGENIC AGENT;

ANIMAL CELL; ARTICLE; BARLEY; CELL LINE; CHEMOPROPHYLAXIS; CHO CELL; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; FEMALE; INCUBATION TIME; MICRONUCLEUS TEST; MUTAGENICITY; NONHUMAN;

ANIMALS; ANTHRACENES; ANTIMUTAGENIC AGENTS; BETA-GLUCANS; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HORDEUM; METHYL METHANESULFONATE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENS;

HORDEUM VULGARE SUBSP. VULGARE;

EID: 33746003662     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.04.001     Document Type: Article

References (38)

1. Abdel-Razzak Z., Corcos L., Fautrel A., Campion J.P., and Guillouzo A. Transforming growth factor-β 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol. Pharmacol. 46 (1994) 1100-1110
2. Borges, V.C., 2001. Alimentos funcionais: prebióticos, probióticos, fitoqui{dotless}́micos e simbióticos. In: Waitzberg, D.L. (Ed.), Nutrição oral, enteral e parenteral na prática cli{dotless}́nica. Atheneu, São Paulo, pp. 1495-1509.
3. Bradham C.A., Plumpe J., Manns M.P., Brenner D.A., and Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Physiol. 275 (1998) 387-392
4. In: Brusick D.J. (Ed). Principles of Genetic Toxicology (1987), Plenum Press, New York 284
5. 60 in mice. Stranhlenther. Onkol. 167 (1991) 612-614
6. De Flora S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 402 (1998) 151-158
7. Di Luzio N.R., Williams D.L., McNamee R.B., Edwards B.F., and Kitahama A. Comparitive tumor-innhibitory and anti-bacterial activity of souble and particulate glucana. Int. J. Cancer 24 (1979) 773-779
8. Falch B.H., Espevik T., Ryan L., and Stokke B.T. The cytokine stimulating activity of (1 → 3)-β-d-glucans is dependent on the triple helix conformation. Carbohyd. Res. 329 (2000) 587-596
9. Fenech M., Crott J., Tuner J., and Brown S. Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measured simultaneously within the cytokinesis-block micronucleus assay: description of method and results for hydrogen peroxide. Mutagenesis 14 (1999) 605-612
10. Ferguson L.R. Antimutagens as cancer chemopreventive agents in the diet. Mutat. Res. 307 (1994) 395-410
11. Ferrari C.K.B., and Torres E.A.F.S. New dietetic compounds with anticarcinogenic properties. Rev. Bras. Cancer 48 (2002) 375-382
12. Flagg E.W., Coates R.J., and Greenberg R.S. Epidemiologic studies of antioxidants and cancer in humans. J. Am. Coll. Nutr. 14 (1995) 419-427
13. Gibson G.R. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J. Nutr. 129 (1999) 1438-1441
14. Hashimoto T., Nonaka Y., Minato K., Kawakami S., Mizuno M., Fukuda I., Kanazawa K., and Ashida H. Suppressive effect of polysaccharides from the edible and medical mushrooms, Letinus edodes and Agaricus blazei, on the expression of cytochrome P450s in mice. Biosci. Biotechnol. Biochem. 66 (2002) 1610-1614
15. Hofer M., and Pospisil M. Glucan as stimulator of hematopoiesis in normal and gamma-irradiated mice: a survey of the authors results. Int. J. Immunopharm. 19 (1997) 607-609
16. Holbrook T.W., Cook J.A., and Parker B.W. Immunization against Leishmania dovavani: glucana as an adjuvant with killed promastigotes. Am. J. Trop. Med. Hyg. 30 (1981) 762-768
17. Kada T., Inoue T., and Namiki N. Environmental desmutagens and antidesmutagens. In: Klekowski E.J. (Ed). Environ. Mutagen. Plant Biol (1982), Praeger, New York 137-151
18. Kada T., and Shimoi K. Desmutagens and bio-antimutagens: their modes of action. Bio Essays 7 (1987) 113-115
19. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Boone C.W., Malone W.A., Haw E.T., Lieberman Lawrence J.A., Kopelovich L., Ali T., Viner J.L., and Sigman C.C. Progress in cancer chemoprevention. NY Acad. Sci. 889 (1999) 1-13
20. Kleiner, S.M., 1997. Defense plants: foods that fight disease. 28 set. 1997. Available in: 〈http://www.physsportsmed.com〉. Access in: 28 September 1998.
21. Lin H., She Y., Cassileth B., Sirotnak F., and Rundles S.C. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int. Immunopharm. 4 (2004) 91-99
22. Maxwell S.R.J. Prospects for the use antioxidant therapies. Drugs 49 (1995) 345-361
23. Meira D.A., Pereira P.C.M., Marcondes-Machado J., Mendes R.P., Barraviera B., Pellegrino J.R.J., Rezkallah-Iwasso M.T., Peraçoli M.T.S., Castilho L.M., Thomzaini I., Silva C.L., Foss N.T., and Curri P.R. The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis. Am. J. Trop. Med. Hyg. 55 (1996) 496-503
24. Milner J.A. Functional foods and health promotion. J. Nutr. 129 (1999) 1395-1397
25. Morgan E.T. Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis. Biochem. Pharmacol. 45 (1993) 415-419
26. Patchen M.L., D'Alesandro M.M., Brook I., Blakely W.F., and Mac Vittie T.J. Glucan: mechanisms involved in its radioproctective effect. J. Leukocyte Biol. 42 (1987) 95-105
27. 4 and neutrophil attractant activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan. J. Clin. Invest. 86 (1990) 1556-1564
28. Raymundo, G.P., 2004. Betaglucana, você conhece? 2004. Available in: 〈http://www.educacional.com.br/〉. Access in: 25 July. 2004.
29. Reynolds J.A., Kastello M.D., Harrigton D.G., Crabs C.L., Peters C.J., Jemski J.V., Scott G.H., and Di Luzio N.R. Glucan-induced enhancement of host resistance to selected infectious diseases. Infect Immun. 30 (1980) 51-57
30. Rossit, A.R.B., Froes, N.D.T.C., 2002. Epidemiologia molecular: xenobióticos e susceptibilidade genética na etiologia do câncer. In: Drumond, I., Juan, L., Llerena Jr, C., Melo, M.S.V., Ashtono-Prolla, P. (Eds.) Genética Molecular do Câncer. MSG Produção Editorial, São Paulo, pp. 31-43.
31. Sies H. Strategies of antioxidant defense. Eur. J. Biochem. 215 (1999) 213-219
32. Slamenová D., Lábaj J., Krizková L., Kogan G., Sandula J., Bresgen N., and Eckl P. Protective effects of fungal (1 → 3)-β-d-glucan derivatives against oxidative DNA lesions in V79 hamster lung cells. Cancer Let. 198 (2003) 153-160
33. Snustad, D.P., Simmons, M.J. (Eds.), 2001. Fundamentos de Genética. Guanabara Koogan, Rio de Janeiro, p. 756.
34. Tohamy A.A., El-Ghor A.A., El-Nahas S.M., and Noshy M.M. β-Glucan inhibits the genotoxicity of cyclophosphamide, adramycin and cisplatin. Mutat. Res. 541 (2003) 45-53
35. Tsiapali E., Whaley S., Kalbfleisch J., Ensley H.E., Browder I.W., and Willians L.D. Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Rad. Biol. Med. 30 (2001) 393-402
36. Tzianabos A.O., and Cisneros R.L. Prophylaxis with the immunomodulator PGG glucana enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria. Ann. NY Acad. Sci. 797 (1996) 285-287
37. Vukicevic V., Kampfinger K., and Stopper H. Influence of altered apoptosis in human lymphoblastoid cell lines on micronucleus frequency. Toxicol. Lett. 147 (2004) 187-195
38. Walter-Sack I., and Klotz U. Influence of diet and nutritional status on drug metabolism. Clin. Pharmacokinet. 31 (1996) 47-64